BRSUX
Price
$16.96
Change
-$0.08 (-0.47%)
Updated
Jul 31 closing price
Net Assets
318.1M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

BRSUX vs VSCIX

BRSUX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
BRSUX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSUX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. BRSUX (318M). VSCIX pays higher dividends than BRSUX: VSCIX (1.23) vs BRSUX (0.56). BRSUX was incepted earlier than VSCIX: BRSUX (11 years) vs VSCIX (29 years). BRSUX (0.88) is less costly to investors than VSCIX (0.03). BRSUX is a more actively managed with annual turnover of: 66.00 vs. VSCIX (17.00). BRSUX has a lower initial minimum investment than VSCIX: BRSUX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. BRSUX (18.68). VSCIX return over 5 years is better than : 35.13 vs. BRSUX (-0.82).
BRSUXVSCIXBRSUX / VSCIX
Total Expense Ratio0.740.032,467%
Annual Report Gross Expense Ratio0.880.032,933%
Fund Existence11 years29 years-
Gain YTD14.82714.591102%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets318M189B0%
Annual Yield % from dividends0.561.2345%
Returns for 1 year18.6822.5883%
Returns for 3 years19.1943.4444%
Returns for 5 years-0.8235.13-2%
Returns for 10 years67.16156.0743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C